Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship
- PMID: 35912881
- DOI: 10.1080/14787210.2022.2108404
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship
Abstract
Background: In Namibia, overuse of medically important antibiotics in animals is common and is a considerable driver of antimicrobial resistance. The study aims to analyze policies, resistance patterns, and consumption of these antibiotics used in animals in Namibia.
Research design and methods: A scoping review and retrospective descriptive analysis of policies, resistance patterns, and use of these antibiotics in Namibia was conducted, and assessed against the Access, Watch and Reserve (AWaRe) antimicrobial use guidance.
Results: Of the forty-five antibiotic products registered for use in animals, 77.8% are Access antibiotics, 68.9% are broad-spectrum and 60% are over-the-counter antibiotics - mainly tetracyclines, penicillins and sulfonamides. There is misalignment of antibiotic use policies for animals and humans and currently no guideline for antibiotic use in animals. Most medically important antibiotics are indicated for control of gastrointestinal (77.7%), musculoskeletal (71.1%), and respiratory (46.7%) infections, and for growth promotion (4.4%). There is high resistance to AWaRe Access antibiotics- sulfonamides (19.5-100%), tetracyclines (56-100%), and penicillin (13.5-100%).
Conclusion: Whilst Namibia banned the use of antibiotics in farming, current policy frameworks are inconsistent across sectors, and promote overuse of broad-spectrum important antibiotics in animals. A multi-sectoral one health approach is required to harmonize antibiotic use policies and reduce resistance.
Keywords: AWaRe; Antibiotics; Namibia; antibiotic resistance; antimicrobial stewardship; policies; veterinary medicine.
Similar articles
-
An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications.Int J Clin Pract. 2017 Feb;71(2). doi: 10.1111/ijcp.12918. Epub 2017 Jan 16. Int J Clin Pract. 2017. PMID: 28090718
-
Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia's national referral hospital: a pilot study and the implications.Expert Rev Anti Infect Ther. 2017 Jul;15(7):713-721. doi: 10.1080/14787210.2017.1320220. Epub 2017 May 5. Expert Rev Anti Infect Ther. 2017. PMID: 28425828
-
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data.Lancet Infect Dis. 2021 Jan;21(1):107-115. doi: 10.1016/S1473-3099(20)30332-7. Epub 2020 Jul 24. Lancet Infect Dis. 2021. PMID: 32717205
-
Antibiotic Stewardship in Food-producing Animals: Challenges, Progress, and Opportunities.Clin Ther. 2020 Sep;42(9):1649-1658. doi: 10.1016/j.clinthera.2020.07.004. Epub 2020 Aug 18. Clin Ther. 2020. PMID: 32819723 Free PMC article. Review.
-
Mapping the Antimicrobial Supply Chain in Bangladesh: A Scoping-Review-Based Ecological Assessment Approach.Glob Health Sci Pract. 2021 Sep 30;9(3):532-547. doi: 10.9745/GHSP-D-20-00502. Print 2021 Sep 30. Glob Health Sci Pract. 2021. PMID: 34593580 Free PMC article.
Cited by
-
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future.Antibiotics (Basel). 2022 Dec 15;11(12):1824. doi: 10.3390/antibiotics11121824. Antibiotics (Basel). 2022. PMID: 36551481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources